Market Overview - The Shanghai Composite Index is at 3555.41 points, with a decline of 0.50% [1] - The total trading volume of A-shares is 128.87 billion yuan [1] Technical Analysis - A total of 64 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Tongzhou Electronics: -1.29% - Marubi Biological: -0.95% - GeKao Micro: -0.69% [1] Individual Stock Performance - Key stock performances include: - Tongzhou Electronics (002052): Today's change -1.15%, 5-day MA at 10.70 yuan, 10-day MA at 10.84 yuan, with a distance of -1.29% [1] - Marubi Biological (603983): Today's change -2.84%, 5-day MA at 39.78 yuan, 10-day MA at 40.16 yuan, with a distance of -0.95% [1] - GeKao Micro (688728): Today's change 0.33%, 5-day MA at 15.71 yuan, 10-day MA at 15.82 yuan, with a distance of -0.69% [1] - Other notable stocks include: - Huatai Securities (601059): Today's change -0.86%, 5-day MA at 16.73 yuan, 10-day MA at 16.84 yuan, with a distance of -0.66% [1] - Jiabao (600622): Today's change -1.01%, 5-day MA at 3.08 yuan, 10-day MA at 3.10 yuan, with a distance of -0.64% [1] Additional Stock Movements - Other stocks with notable movements include: - Laka Laka (300773): Today's change -4.02%, 5-day MA at 27.62 yuan, 10-day MA at 27.73 yuan, with a distance of -0.39% [2] - Yongtai Technology (002326): Today's change 4.09%, 5-day MA at 13.25 yuan, 10-day MA at 13.29 yuan, with a distance of -0.32% [2] - Qijing (603677): Today's change -0.46%, 5-day MA at 19.91 yuan, 10-day MA at 19.96 yuan, with a distance of -0.25% [2]

Group 1 - Major shareholder,融科创投, holds 20,463,622 shares of the company, accounting for 8.3403% of total shares [2] -融科创投 plans to reduce its holdings by up to 2,453,592 shares, not exceeding 1% of the total share capital, due to funding needs [3][4] - The reduction period is set for three months starting 15 trading days after the announcement, with prices determined by market conditions [3][7] Group 2 -融科创投 has previously reduced its holdings by 2,452,088 shares through centralized bidding and 4,907,000 shares through block trading in the past 12 months [6] -融科创投 has made commitments regarding share lock-up and reduction intentions, including not transferring shares for 36 months post-IPO [9][10] - The company will comply with relevant laws and regulations regarding the reduction plan and will disclose information as required [14]

证券代码：688063 证券简称：派能科技 公告编号：2025-051 上海派能能源科技股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 大股东持股的基本情况 截至本公告披露日，派锂（宁波）创业投资合伙企业（有限合伙）（以下简 称"融科创投"）直接持有上海派能能源科技股份有限公司（以下简称"公司" 或"派能科技"）股份 20,463,622 股，占公司总股本的 8.3403%。上述股份来源 为公司首次公开发行股票前持有的股份及上市后权益分派以资本公积金转增股 本取得的股份，首次公开发行股票前持有的股份于 2024 年 1 月 2 日起上市流通。 ? 减持计划的主要内容 融科创投因自身资金周转需求，拟通过集中竞价交易方式减持公司股份数量 合计不超过 2,453,592 股，减持比例不超过公司总股本的 1%。 减持期间为自本公告披露之日起 15 个交易日后的 3 个月内。减持价格按市 场价格确定，若公司在上述减持计划实施期间发生派发红利、送股、资本 ...

Core Insights - Jiangnan Yifan disclosed plans to increase its shareholding by no less than 50,000 shares and no more than 100,000 shares [1] - A total of 14 A-share listed companies announced share reductions, including *ST Dongjing, Hanwang Technology, Heyuan Gas, and others [1] Summary of Shareholding Changes - Jiangnan Yifan: Plans to increase shareholding by 50,000 to 100,000 shares [2] - Hanwang Technology: Director Li Zhifeng plans to reduce holdings by up to 0.0525% [2] - Heyuan Gas: Changjiang Capital plans to reduce holdings by up to 2% [2] - Jieya Shares: Shareholder plans to reduce holdings by up to 4.95% [2] - Pioneering Technology: Shareholder Rongke Chuangtou plans to reduce holdings by up to 1% [2] - Xinling Electric: Director Zhang Pengchun plans to reduce holdings by up to 0.40% [2] - Tongda Shares: Shareholder Huasheng Baili plans to reduce holdings by up to 3% [2] - Yuxin Electronics: Hu Xinrui plans to transfer up to 1 million shares to a related party [2] - Jiusheng Electric: Employee representative director Xu Ming plans to reduce holdings by up to 0.07% [2] - Enwei Medical: Vice President Chen Lei plans to reduce holdings by up to 16,279 shares [2] - Wanhua Chemical: Shareholder plans to reduce holdings by up to 0.54% [2] - Haohan Depth: Shareholder Lianchuang Yongqin plans to reduce holdings by up to 2.17% [2] - Jiahua Technology: Shareholder Gongqingcheng Huayun plans to reduce holdings by up to 2% [2] - Weizhi Xiang: Major shareholder Jinhua Sheng plans to reduce holdings by up to 0.43% [2]

Core Viewpoint - On July 31, Jiangnan Yifan disclosed shareholding changes, with 14 A-share listed companies announcing share reductions, while Jiangnan Tufan planned to increase its shareholding [1][2]. Group 1: Shareholding Increases - Jiangnan Tufan's Liu Songyan plans to increase his shareholding by no less than 50,000 shares and no more than 100,000 shares [2]. Group 2: Shareholding Reductions - *ST Dongjing: Shareholder Ningbo Ningju plans to reduce holdings by no more than 2.43 million shares [2]. - Hanwang Technology: Director and senior manager Li Zhifeng intends to reduce holdings by no more than 0.0525% of the company's shares [2]. - Heyuan Gas: Changjiang Capital plans to reduce holdings by no more than 2% of the company's shares [2]. - Jieya Shares: Shareholders plan to reduce holdings by no more than 4.95% of the company's shares [2]. - Pioneering Technology: Shareholder Rongke Chuangtou plans to reduce holdings by no more than 1% of the company's shares [2]. - Xinling Electric: Director and General Manager Zhang Pengchun plans to reduce holdings by no more than 0.40% of the company's shares [2]. - Tongda Shares: Shareholder Huasheng Baili plans to reduce holdings by no more than 3% [2]. - Yuxin Electronics: Hu Xinrui plans to transfer no more than 1 million shares to his concerted action person Li Yun [2]. - Jiusheng Electric: Employee representative director Xu Ming plans to reduce holdings by no more than 0.07% of the company's shares [2]. - Enwei Pharmaceutical: Vice President Chen Lei plans to reduce holdings by no more than 16,279 shares [2]. - Wanhua Chemical: Shareholders plan to reduce holdings by no more than 0.54% of the company's shares [2]. - Haohan Depth: Shareholder Lianchuang Yongqin plans to reduce holdings by no more than 2.17% of the company's shares [2]. - Jiahua Technology: Gongqingcheng Huayun plans to reduce holdings by no more than 2% of the company's shares [2]. - Weizhi Flavor: Shareholder Jinhua Sheng plans to reduce holdings by no more than 0.43% of the company's shares [2].

| | | 8月1日A股投资避雷针 | | --- | --- | --- | | 类别 | 公司 | 主要内容 | | | *ST东晶 | 宁波宁聚拟减持不超243万股 | | | 洁雅股份 | 明源基金及其一致行动人拟减持合计不超4.95%股份 | | | 和远气体 | 大股东长江资本拟减持合计不超2%股份 | | | 派能科技 | 融科创投拟减持不超过1%股份 | | | 欣灵电气 | 总经理张彭春拟减持不超过0.4%股份 | | | 同大股份 | 华盛百利拟减持不超过3%股份 | | 股东减持 | 浩瀚深度 | 股东联创永钦拟减持不超2.1733%股份 | | | 万华化学 | Prime Partner拟减持不超0.54%的股份 | | | 佳华科技 | 共青城华云拟减持不超过2%股份 | | | 国茂股份 | 徐彬、徐国忠合计减持652.61万股股份 | | | 味知香 | 金花生拟减持不超60万股股份 | | | 华依科技 | 秦立罡累计减持1.5%股份 | | 其他 | 禾望电气 | 目前公司尚无HVDC产品 | | | 安正时尚 | 控股公司礼尚信息未从事母婴产品的相关生产 国际图 | 洁雅 ...

Group 1: Clinical Trials and Approvals - Heng Rui Medicine received clinical trial approval for HRS-5041 tablets for prostate cancer treatment, a novel AR-PROTAC small molecule with potential to overcome resistance compared to second-generation AR inhibitors [1] - Microchip Biotech's CS231295 tablets received FDA approval for a Phase I clinical trial targeting advanced solid tumors, noted for its ability to penetrate the blood-brain barrier [2] - Shuyuan obtained a summary report for BDB-001 injection, showing significant clinical advantages in reducing hormone dosage for ANCA-associated vasculitis, with plans to advance to Phase III trials [5] - Huayi Pharmaceutical's HSK3486 received FDA application acceptance for marketing [12] Group 2: Financial Performance - Daodaoquan reported a 563.15% increase in net profit for the first half of 2025, with revenue of 2.792 billion yuan, driven by improved sales and reduced raw material costs [4] - China Petroleum and Chemical Corporation (Sinopec) expects a net profit of 20.1 billion to 21.6 billion yuan for the first half of 2025, reflecting a decline due to falling oil prices and market competition [6] Group 3: Shareholder Actions - Wanhua Chemical's major shareholder plans to reduce its stake by up to 0.54%, equating to no more than 17 million shares, due to personal financial needs [2] - Ding Tong Technology's controlling shareholder intends to transfer 3% of the company's shares, totaling 417.6 million shares, for similar financial reasons [7] Group 4: New Projects and Investments - Guo En Co., Ltd. announced a project to establish a new platform for PEEK and polystyrene engineering materials with an investment of 960 million yuan, enhancing competitiveness in specialty engineering plastics [8] - Shanying International plans to establish a partnership with a valuation of 2.977 billion yuan to attract long-term investors, including state-owned capital [8]

格隆汇7月31日丨派能科技(688063.SH)公告称，公司股东融科创投因自身资金周转需求，拟通过集中竞 价交易方式减持公司股份数量合计不超过245万股，减持比例不超过公司总股本的1%。减持期间为自本 公告披露之日起15个交易日后的3个月内。 ...

格隆汇7月31日丨派能科技(688063.SH)公布，融科创投因自身资金周转需求，拟通过集中竞价交易方式 减持公司股份数量合计不超过245.35万股，减持比例不超过公司总股本的1%。减持期间为自本公告披 露之日起15个交易日后的3个月内。减持价格按市场价格确定。 ...

证券代码：688063 证券简称：派能科技 公告编号：2025-051 上海派能能源科技股份有限公司 持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持股的基本情况 截至本公告披露日，派锂（宁波）创业投资合伙企业（有限合伙）（以下简 称"融科创投"）直接持有上海派能能源科技股份有限公司（以下简称"公司" 或"派能科技"）股份 20,463,622 股，占公司总股本的 8.3403%。上述股份来源 为公司首次公开发行股票前持有的股份及上市后权益分派以资本公积金转增股 本取得的股份，首次公开发行股票前持有的股份于 2024 年 1 月 2 日起上市流通。 减持计划的主要内容 融科创投因自身资金周转需求，拟通过集中竞价交易方式减持公司股份数量 合计不超过 2,453,592 股，减持比例不超过公司总股本的 1%。 减持期间为自本公告披露之日起 15 个交易日后的 3 个月内。减持价格按市 场价格确定，若公司在上述减持计划实施期间发生派发红利、送股、资本公积转 ...